US · Healthcare

Multicorp Intl Inc. (MCIC)

Drug Manufacturers - Specialty & Generic

Multicorp Intl Inc. (MCIC) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MCIC

P/E ratio

18.00

Multicorp Intl Inc. (MCIC) — FAQ

What is MCIC's P/E ratio?

The price-to-earnings (P/E) ratio for Multicorp Intl Inc. (MCIC) is 18.00 (data as of 2026-05-23).

Does Multicorp Intl Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Multicorp Intl Inc. (MCIC). Check the MyAverix Finance app for the latest dividend data.

What sector is Multicorp Intl Inc. in?

Multicorp Intl Inc. (MCIC) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is MCIC listed on?

MCIC is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)